238 related articles for article (PubMed ID: 30237756)
1. The Molecular Basis of Metastatic Colorectal Cancer.
Andres SF; Williams KN; Rustgi AK
Curr Colorectal Cancer Rep; 2018 Apr; 14(2):69-79. PubMed ID: 30237756
[TBL] [Abstract][Full Text] [Related]
2. Preclinical Identification of Sulfasalazine's Therapeutic Potential for Suppressing Colorectal Cancer Stemness and Metastasis through Targeting KRAS/MMP7/CD44 Signaling.
Leung WH; Shih JW; Chen JS; Mokgautsi N; Wei PL; Huang YJ
Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203586
[TBL] [Abstract][Full Text] [Related]
3. RHBDD1 promotes colorectal cancer metastasis through the Wnt signaling pathway and its downstream target ZEB1.
Zhang M; Miao F; Huang R; Liu W; Zhao Y; Jiao T; Lu Y; Wu F; Wang X; Wang H; Zhao H; Ju H; Miao S; Wang L; Song W
J Exp Clin Cancer Res; 2018 Feb; 37(1):22. PubMed ID: 29426364
[TBL] [Abstract][Full Text] [Related]
4. KRAS Mutation-Responsive miR-139-5p inhibits Colorectal Cancer Progression and is repressed by Wnt Signaling.
Du F; Cao T; Xie H; Li T; Sun L; Liu H; Guo H; Wang X; Liu Q; Kim T; Franklin JL; Graves-Deal R; Han W; Tian Z; Ge M; Nie Y; Fan D; Coffey RJ; Lu Y; Zhao X
Theranostics; 2020; 10(16):7335-7350. PubMed ID: 32641995
[No Abstract] [Full Text] [Related]
5. Human colorectal cancer-derived carcinoma associated fibroblasts promote CD44-mediated adhesion of colorectal cancer cells to endothelial cells by secretion of HGF.
Zhang R; Qi F; Shao S; Li G; Feng Y
Cancer Cell Int; 2019; 19():192. PubMed ID: 31367190
[TBL] [Abstract][Full Text] [Related]
6. Decreased levels of miR-224 and the passenger strand of miR-221 increase MBD2, suppressing maspin and promoting colorectal tumor growth and metastasis in mice.
Yuan K; Xie K; Fox J; Zeng H; Gao H; Huang C; Wu M
Gastroenterology; 2013 Oct; 145(4):853-64.e9. PubMed ID: 23770133
[TBL] [Abstract][Full Text] [Related]
7. miR-302a Inhibits Metastasis and Cetuximab Resistance in Colorectal Cancer by Targeting NFIB and CD44.
Sun L; Fang Y; Wang X; Han Y; Du F; Li C; Hu H; Liu H; Liu Q; Wang J; Liang J; Chen P; Yang H; Nie Y; Wu K; Fan D; Coffey RJ; Lu Y; Zhao X; Wang X
Theranostics; 2019; 9(26):8409-8425. PubMed ID: 31754405
[No Abstract] [Full Text] [Related]
8. Preclinical Evaluation of a Novel Small Molecule LCC-21 to Suppress Colorectal Cancer Malignancy by Inhibiting Angiogenic and Metastatic Signatures.
Mokgautsi N; Kuo YC; Huang YJ; Chen CH; Mukhopadhyay D; Wu ATH; Huang HS
Cells; 2023 Jan; 12(2):. PubMed ID: 36672201
[TBL] [Abstract][Full Text] [Related]
9. FUBP1 promotes colorectal cancer stemness and metastasis via DVL1-mediated activation of Wnt/β-catenin signaling.
Yin H; Gao T; Xie J; Huang Z; Zhang X; Yang F; Qi W; Yang Z; Zhou T; Gao G; Yang X
Mol Oncol; 2021 Dec; 15(12):3490-3512. PubMed ID: 34288405
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-induced lncRNA STEAP3-AS1 activates Wnt/β-catenin signaling to promote colorectal cancer progression by preventing m
Zhou L; Jiang J; Huang Z; Jin P; Peng L; Luo M; Zhang Z; Chen Y; Xie N; Gao W; Nice EC; Li JQ; Chen HN; Huang C
Mol Cancer; 2022 Aug; 21(1):168. PubMed ID: 35986274
[TBL] [Abstract][Full Text] [Related]
11. MiR-384 inhibits human colorectal cancer metastasis by targeting KRAS and CDC42.
Wang YX; Chen YR; Liu SS; Ye YP; Jiao HL; Wang SY; Xiao ZY; Wei WT; Qiu JF; Liang L; Liao WT; Ding YQ
Oncotarget; 2016 Dec; 7(51):84826-84838. PubMed ID: 27769041
[TBL] [Abstract][Full Text] [Related]
12. Metastatic colorectal cancer cells maintain the TGFβ program and use TGFBI to fuel angiogenesis.
Chiavarina B; Costanza B; Ronca R; Blomme A; Rezzola S; Chiodelli P; Giguelay A; Belthier G; Doumont G; Van Simaeys G; Lacroix S; Yokobori T; Erkhem-Ochir B; Balaguer P; Cavailles V; Fabbrizio E; Di Valentin E; Gofflot S; Detry O; Jerusalem G; Goldman S; Delvenne P; Bellahcène A; Pannequin J; Castronovo V; Turtoi A
Theranostics; 2021; 11(4):1626-1640. PubMed ID: 33408771
[TBL] [Abstract][Full Text] [Related]
13. A let-7 microRNA SNP in the KRAS 3'UTR is prognostic in early-stage colorectal cancer.
Smits KM; Paranjape T; Nallur S; Wouters KA; Weijenberg MP; Schouten LJ; van den Brandt PA; Bosman FT; Weidhaas JB; van Engeland M
Clin Cancer Res; 2011 Dec; 17(24):7723-31. PubMed ID: 21994416
[TBL] [Abstract][Full Text] [Related]
14. New Wnt/β-catenin target genes promote experimental metastasis and migration of colorectal cancer cells through different signals.
Qi J; Yu Y; Akilli Öztürk Ö; Holland JD; Besser D; Fritzmann J; Wulf-Goldenberg A; Eckert K; Fichtner I; Birchmeier W
Gut; 2016 Oct; 65(10):1690-701. PubMed ID: 26156959
[TBL] [Abstract][Full Text] [Related]
15. miR-4775 promotes colorectal cancer invasion and metastasis via the Smad7/TGFβ-mediated epithelial to mesenchymal transition.
Zhao S; Sun H; Jiang W; Mi Y; Zhang D; Wen Y; Cheng D; Tang H; Wu S; Yu Y; Liu X; Cui W; Zhang M; Sun X; Zhou Z; Peng Z; Yan D
Mol Cancer; 2017 Jan; 16(1):12. PubMed ID: 28095858
[TBL] [Abstract][Full Text] [Related]
16.
Ottaiano A; Sabbatino F; Perri F; Cascella M; Sirica R; Patrone R; Capuozzo M; Savarese G; Ianniello M; Petrillo N; Circelli L; Granata V; Berretta M; Santorsola M; Nasti G
Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509241
[No Abstract] [Full Text] [Related]
17. The Role of Targeted Therapy in the Multi-Disciplinary Approach to Colorectal Liver Metastasis.
Ruff SM; Shannon AH; Pawlik TM
Cancers (Basel); 2023 Jul; 15(13):. PubMed ID: 37444625
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of KRAS and BRAF in stage I-III colorectal cancer. A systematic review.
Gallo G; Sena G; Vescio G; Papandrea M; Sacco R; Trompetto M; Sammarco G
Ann Ital Chir; 2019; 90():127-137. PubMed ID: 30739887
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA Linc00675 suppresses cell proliferation and metastasis in colorectal cancer via acting on miR-942 and Wnt/β-catenin signaling.
Shan Z; An N; Qin J; Yang J; Sun H; Yang W
Biomed Pharmacother; 2018 May; 101():769-776. PubMed ID: 29524886
[TBL] [Abstract][Full Text] [Related]
20. Molecular functions of microRNAs in colorectal cancer: recent roles in proliferation, angiogenesis, apoptosis, and chemoresistance.
Ellakwa DE; Mushtaq N; Khan S; Jabbar A; Abdelmalek MA; Wadan AS; Ellakwa TE; Raza A
Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; ():. PubMed ID: 38619588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
